Natural health product · NPN 80116167
FlexJointPlus
Yes: licensed in Canada
The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.
Licence status Active; licensed February 5, 2022; licence last revised April 20, 2022.
- Natural Product Number (NPN)
- 80116167
- Licence holder
- J2K Interactive Inc.
- Dosage form
- Capsule
- Route
- Oral
- Licensing route
- General (non-traditional)
- First licensed
- February 5, 2022
- Licence last revised
- April 20, 2022
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| Grape seed extract | 50 mg | Vitis vinifera - Seed; 95 % Proanthocyanidins |
| Boron | 0.65 mg | Borax |
| Partially hydrolysed chicken eggshell membrane | 250 mg | |
| Vitamin D | 12.5 microgram | Cholecalciferol |
| Curcuma longa | 150 mg | Curcuma longa - rhizome |
| Boswellia serrata | 50 mg | Boswellia serrata - Stem bark oleogum resin; 70 % Boswellic acids; 5.000:1 Dry; equivalent to 250 mg dried herb |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- Source of/Provides antioxidants. Helps maintain healthy calcium metabolism. Calcium intake, when combined with sufficient Vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Helps (to) maintain/support immune function. Helps in the absorption (and use) of calcium and phosphorus. Helps in the development and maintenance of bones and teeth. Helps to build strong bones and teeth. Helps to prevent vitamin D deficiency. Helps with immune function. Helps to improve recovery from joint pain and stiffness due to moderate intensity aerobic exercise in post-menopausal women. Helps to minimize discomfort due to moderate intensity aerobic exercise in postmenopausal women. Helps reduce levels of CTX-II, a biomarker/marker of cartilage degradation due to moderate intensity aerobic exercise in post-menopausal women. Helps reduce levels of CTX-II, a biomarker/marker of joint degradation due to moderate intensity aerobic exercise in post-menopausal women. Helps to improve recovery from joint pain and stiffness due to moderate intensity aerobic exercise. Helps to minimize discomfort due to moderate intensity aerobic exercise. Helps reduce levels of CTX-II, a biomarker/marker of cartilage degradation due to moderate intensity aerobic exercise. Helps reduce levels of CTX-II, a biomarker/marker of joint degradation due to moderate intensity aerobic exercise. (NEM) Starts to reduce joint pain due to moderate intensity aerobic exercise in as little/as quickly as 1 day and joint stiffness in as little/as quickly as 5 days. (NEM is) Clinically proven to provide relief from joint stiffness due to moderate intensity aerobic exercise (in as little as 5-7 days). (NEM) Helps provide relief from joint pain due to moderate intensity aerobic exercise (as quickly as the first day).
Non-medicinal ingredients
Gelatin; Silica; Rice flour; Magnesium stearate